🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 29% of ingredients have research evidence
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

2 Tablet(s) Serving Size
30 Servings
Other Combinations Product Type
29% Evidence Coverage

Supplement Facts — Evidence Check

100% Whole Food Nutrients
15 mg (100% DV)
✅ 1.4× RDA — within safe limits 📚 258 studies (Tier A: 6, B: 134)
RDA 11mg This product: 15mg UL 40mg
350 mg
📊 Market median: 500.0mg (180 products) 📚 5 studies (Tier A: 0, B: 1)
This product: 350mg
Additional Foods & Extracts
143 mg
Botanical Extracts
870 mg
Immune Blend
300 mg
Bioactive Enzymes & Proteins
162 mg

Other Ingredients

Vegetable Cellulose Rice Bran Silica Vegetable Lubricant Guar Gum

Label Claims — Verification

All Other
All Other (98% of products) Structure/Function (78% of products) Nutrient (56% of products)

Target Groups

Vegetarian Adult Male (18-50 Years) Seniors/Mature (>50 Years) - Men ONLY Gluten Free Dairy Free

Product Information

📋 Directions for Use

Suggested Use: 2 tablets daily, or as directed by your healthcare practitioner.

🧪 Formulation Notes

Free of Pesticides, Herbicides & Corn

- Nothing Artificial or Synthetic - Tested Free of Gluten, Dairy or Soy

- Suitable for Vegetarians

Additional Information

Naturally occurring

Clinical Strength - Professional Use Only

organically grown foods & herbs

- GMP Compliant

vis medicatrix naturae

EXCEPTIONALLY PURE 100% WHOLE FOOD NUTRIENTS

Made in USA

603-216-0899

Product Code #40092 F1305B-10 Rev: 4 12/09

Please Recycle

Broad Spectrum Multi-Component Finished Good Tested

100% WHOLE FOOD Derived From Raw Foods Tested & Assayed for Potency & Purity

Product Details

UPC / SKU 0 51494 40092 0
DSLD Entry Date 2013-08-23
Product Type Other Combinations
Form Tablet or Pill
DSLD ID 24528
Data Updated 2026-04-11

Research Evidence

50 Research Sources
47 Avg Quality Score
28 Rct
13 Clinical Trial
5 Guideline
4 Systematic Review
A Using a Novel Consensus-Based Chemoinformatics Approach to Predict ADMET Properties and Druglikeness of Tyrosine Kinase Inhibitors.
Guideline International journal of molecular sciences 2025
B Australia and New Zealand consensus statement on the cardiovascular management of patients with chronic lymphocytic leukaemia treated with Bruton's tyrosine kinase inhibitors.
Guideline Internal medicine journal 2025
B Branched-chain amino acid supplementation for improving growth and development in term and preterm neonates
Systematic Review The Cochrane database of systematic reviews 2020
B [Clinical practice guideline on anaplastic lymphoma kinase-tyrosine kinase inhibitors for non-small cell lung cancer (2025 edition)].
Guideline Zhonghua zhong liu za zhi [Chinese journal of oncology] 2025
B [Chinese expert consensus on epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small cell lung cancer (2025 edition)].
Guideline Zhonghua yi xue za zhi 2025
B Consensus Guideline for the Diagnosis and Treatment of Tyrosine Hydroxylase (TH) Deficiency.
Guideline Journal of inherited metabolic disease 2025
B Baseline-dependent effect of dopamine's precursor L-tyrosine on working memory gating but not updating
Rct Cognitive, affective & behavioral neuroscience 2020
B Effect of Amino Acid Supplementation on Iron Regulation after Endurance Exercise
Rct Nutrients 2023
C Attenuating Muscle Damage Biomarkers and Muscle Soreness After an Exercise-Induced Muscle Damage with Branched-Chain Amino Acid (BCAA) Supplementation: A Systematic Review and Meta-analysis with Meta-regression
Systematic Review Sports medicine - open 2024
C The Effects of Green Tea Amino Acid L-Theanine Consumption on the Ability to Manage Stress and Anxiety Levels: a Systematic Review
Systematic Review Plant foods for human nutrition (Dordrecht, Netherlands) 2020
View all evidence for Tyrosine →

Compare Similar Products

View all Tyrosine products →